CLINICAL_TRIALS
trial_result
· 2009-11-26
Clinical Trial Update: Juvenile Rheumatoid Arthritis [Phase 2]
Summary
Amgen has completed a Phase 2 clinical trial for juvenile idiopathic arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Amgen | Conditions: Juvenile Chronic Arthritis | Phase 2 | Status: COMPLETED